Literature DB >> 21607560

Secondary neuropsychiatric manifestations caused by Epstein-Barr virus encephalitis in a new onset systemic lupus erythematosus patient.

Chen Hongbo1, Ma Hongzhen, He Lingzhi, Xu Maosheng, Chen Mei.   

Abstract

Abnormal manifestations of central nervous system in system lupus erythematosus (SLE) patients are mainly caused by primary neuropsychiatric SLE (NP-SLE). We reported a new onset SLE patient who had secondary neuropsychiatric manifestations caused by Epstein-Barr virus (EBV) encephalitis. Although EBV has an uncertain association with SLE, Epstein-Barr virus encephalitis occurred in active SLE patients was not reported previously. Our report may be the first case about EBV encephalitis occurred in active SLE.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21607560     DOI： 10.1007/s00296-011-1877-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  14 in total

1.  Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype.

Authors:  Christine G Parks; Glinda S Cooper; Lori L Hudson; Mary Anne Dooley; Edward L Treadwell; E W St Clair; Gary S Gilkeson; Janardan P Pandey
Journal:  Arthritis Rheum       Date:  2005-04

2.  EBV and systemic lupus erythematosus: a new perspective.

Authors:  Andrew J Gross; Donna Hochberg; William M Rand; David A Thorley-Lawson
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

Review 3.  Epstein-Barr virus infection induces lupus autoimmunity.

Authors:  John B Harley; Judith A James
Journal:  Bull NYU Hosp Jt Dis       Date:  2006

4.  Systemic lupus erythematosus and concurrent cytomegalovirus vasculitis: diagnosis by antemortem skin biopsy.

Authors:  K J Bulpitt; E Brahn
Journal:  J Rheumatol       Date:  1989-05       Impact factor: 4.666

5.  Successful acyclovir treatment of herpes simplex type 2 hepatitis in a patient with systemic lupus erythematosus: a case report and meta analysis.

Authors:  A B Chung; N Fas
Journal:  Am J Med Sci       Date:  1998-12       Impact factor: 2.378

Review 6.  Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?

Authors:  Spyros Aslanidis; Athina Pyrpasopoulou; Kostas Kontotasios; Stella Doumas; Chryssanthos Zamboulis
Journal:  Eur J Intern Med       Date:  2007-11-19       Impact factor: 4.487

Review 7.  Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature.

Authors:  Manuel Ramos-Casals; María José Cuadrado; Paula Alba; Giovanni Sanna; Pilar Brito-Zerón; Laura Bertolaccini; Alejandra Babini; Asunción Moreno; David D'Cruz; Munther A Khamashta
Journal:  Medicine (Baltimore)       Date:  2008-11       Impact factor: 1.889

8.  Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.

Authors:  Insoo Kang; Timothy Quan; Helena Nolasco; Sung-Hwan Park; Myung Sun Hong; Jill Crouch; Eric G Pamer; John Greg Howe; Joe Craft
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

Review 9.  The neuroanatomic localization of Epstein-Barr virus encephalitis may be a predictive factor for its clinical outcome: a case report and review of 100 cases in 28 reports.

Authors:  Kasim Abul-Kasim; Lars Palm; Pavel Maly; Pia C Sundgren
Journal:  J Child Neurol       Date:  2009-01-16       Impact factor: 1.987

10.  [Epstein-Barr virus-associated encephalitis presenting as refractory status epilepticus that persisted for nearly 2 months with excellent recovery].

Authors:  Makoto Nishie; Masaya Ogawa; Kozo Kurahashi
Journal:  Rinsho Shinkeigaku       Date:  2003-07
View more
  1 in total

Review 1.  Lupus and Epstein-Barr.

Authors:  Judith A James; Julie M Robertson
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.